Related references
Note: Only part of the references are listed.Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
Juanjuan Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
Jessica B. Foster et al.
MOLECULAR THERAPY (2019)
The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
Jianxiang Zhang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Target selection for CAR-T therapy
Jianshu Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens
Aaron M. Miller et al.
CANCER IMMUNOLOGY RESEARCH (2019)
T-cell receptor-engineered T cells for cancer treatment: current status and future directions
Yu Ping et al.
PROTEIN & CELL (2018)
Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts
Ping-Pin Zheng et al.
DRUG DISCOVERY TODAY (2018)
Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
Jian Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity
Dongrui Wang et al.
JCI INSIGHT (2018)
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
Mateusz Legut et al.
BLOOD (2018)
Immunotherapy against cancer-related viruses
Haruko Tashiro et al.
CELL RESEARCH (2017)
Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells
Caroline Boudousquie et al.
IMMUNOLOGY (2017)
Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
Bingshan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
T memory stem cells in health and disease
Luca Gattinoni et al.
NATURE MEDICINE (2017)
Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
Danilo Presotto et al.
FRONTIERS IN IMMUNOLOGY (2017)
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS
Isao Tawara et al.
BLOOD (2017)
The urgent need to recover MHC class I in cancers for effective immunotherapy
Federico Garrido et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma
Ugur Uslu et al.
EXPERIMENTAL DERMATOLOGY (2016)
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
Shinichi Kageyama et al.
CLINICAL CANCER RESEARCH (2015)
Translational Implications of Tumor Heterogeneity
Mariam Jamal-Hanjani et al.
CLINICAL CANCER RESEARCH (2015)
T-cell receptor gene therapy - ready to go-viral?
Terhi Karpanen et al.
MOLECULAR ONCOLOGY (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Lower affinity T cells are critical components and active participants of the immune response
Ryan J. Martinez et al.
FRONTIERS IN IMMUNOLOGY (2015)
Oncogenic viruses and cancer
Guangxiang George Luo et al.
VIROLOGICA SINICA (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
Target Antigen Density Governs the Efficacy of Anti-CD20-CD28-CD3 ζ Chimeric Antigen Receptor-Modified Effector CD8+ T Cells
Keisuke Watanabe et al.
JOURNAL OF IMMUNOLOGY (2015)
ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells
Giovanna Bossi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
CAR T Cells for Solid Tumors Armed and Ready to Go?
Sunitha Kakarla et al.
CANCER JOURNAL (2014)
Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
Thinle Chodon et al.
CLINICAL CANCER RESEARCH (2014)
TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
B. Berdien et al.
GENE THERAPY (2014)
TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity
Coen Govers et al.
JOURNAL OF IMMUNOLOGY (2014)
RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer
Mario Bunse et al.
MOLECULAR THERAPY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Pathways of Antigen Processing
Janice S. Blum et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette et al.
BLOOD (2013)
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1-and LAGE-1-positive tumors
Emmet McCormack et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
A Single Peptide-Major Histocompatibility Complex Ligand Triggers Digital Cytokine Secretion in CD4+ T Cells
Jun Huang et al.
IMMUNITY (2013)
SHP-1 phosphatase activity counteracts increased T cell receptor affinity
Michael Hebeisen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Richard A. Morgan et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Introduction of Exogenous T-cell Receptors Into Human Hematopoietic Progenitors Results in Exclusion of Endogenous T-cell Receptor Expression
Dimitrios N. Vatakis et al.
MOLECULAR THERAPY (2013)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Cor H. J. Lamers et al.
MOLECULAR THERAPY (2013)
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy
Shi Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
Brian J. Cameron et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitenss, and sensitization of tumor milieu
Andre Kunert et al.
FRONTIERS IN IMMUNOLOGY (2013)
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
Hiroki Torikai et al.
BLOOD (2012)
Dissection of T-cell Antigen Specificity in Human Melanoma
Rikke Sick Andersen et al.
CANCER RESEARCH (2012)
Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
Milos Aleksic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Monoclonal TCR-redirected tumor cell killing
Nathaniel Liddy et al.
NATURE MEDICINE (2012)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell engagers (BiTEs)
Jennifer D. Stone et al.
ONCOIMMUNOLOGY (2012)
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
Toshiki Ochi et al.
BLOOD (2011)
In Vivo Programming of Tumor Antigen-Specific T Lymphocytes from Pluripotent Stem Cells to Promote Cancer Immunosurveillance
Fengyang Lei et al.
CANCER RESEARCH (2011)
Phase I Trial of ALT-801, an Interleukin-2/T-Cell Receptor Fusion Protein Targeting p53 (aa264-272)/HLA-A*0201 Complex, in Patients with Advanced Malignancies
Mayer N. Fishman et al.
CLINICAL CANCER RESEARCH (2011)
Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
David M. Barrett et al.
HUMAN GENE THERAPY (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses
Emily Corse et al.
JOURNAL OF IMMUNOLOGY (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
When MAGE meets RING: insights into biological functions of MAGE proteins
Yue Feng et al.
PROTEIN & CELL (2011)
Mechanisms for T cell receptor triggering
P. Anton van der Merwe et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Jacques Neefjes et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy Trials
Jeremy L. Davis et al.
CLINICAL CANCER RESEARCH (2010)
Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function
Daphne A. Schmid et al.
JOURNAL OF IMMUNOLOGY (2010)
Of Mice, Not Men: No Evidence for Graft-versus-Host Disease in Humans Receiving T-Cell Receptor-Transduced Autologous T Cells
Steven A. Rosenberg
MOLECULAR THERAPY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
Gavin M. Bendle et al.
NATURE MEDICINE (2010)
Mixed T cell receptor dimers harbor potentially harmful neoreactivity
Marleen M. van Loenen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structural Biology of the T-cell Receptor: Insights into Receptor Assembly, Ligand Recognition, and Initiation of Signaling
Kai W. Wucherpfennig et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR
Sachiko Okamoto et al.
CANCER RESEARCH (2009)
Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2009)
The T-cell-receptor signaling network
Morgan Huse
JOURNAL OF CELL SCIENCE (2009)
Complete but curtailed T-cell response to very low-affinity antigen
Dietmar Zehn et al.
NATURE (2009)
Targeting activity of a TCR/IL-2 fusion protein against established tumors
Jinghai Wen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Balancing between Antitumor Efficacy and Autoimmune Pathology in T-Cell-Mediated Targeting of Carcinoembryonic Antigen
Rinke Bos et al.
CANCER RESEARCH (2008)
Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease
Vincent G. Brichard et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition
S. Yang et al.
GENE THERAPY (2008)
Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells
S. B. Justin Wong et al.
JOURNAL OF IMMUNOLOGY (2008)
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
Douglas C. Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genome-wide analysis of cancer/testis gene expression
Oliver Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular design of the C alpha beta interface favors specific pairing of introduced TCR alpha beta in human T cells
Ralf-Holger Voss et al.
JOURNAL OF IMMUNOLOGY (2008)
Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo
Cor H. J. Lamers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma
Julie R. Park et al.
MOLECULAR THERAPY (2007)
Facilitating matched pairing and expression of TCR chains introduced into human T cells
Jurgen Kuball et al.
BLOOD (2007)
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer
Celia Groeper et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes
Laura A. Johnson et al.
JOURNAL OF IMMUNOLOGY (2006)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein
Heather J. Belmont et al.
CLINICAL IMMUNOLOGY (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents
Martin Monte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The clinical significance of MAGEA3 expression in pancreatic cancer
J Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition
GG Callender et al.
HEPATOLOGY (2006)
αβ T-cell receptor engineered γδ T cells mediate effective antileukemic reactivity
LT van der Veken et al.
CANCER RESEARCH (2006)
Visualization of p53264-272/HLA-A*0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor
Xiaoyun Zhu et al.
JOURNAL OF IMMUNOLOGY (2006)
Safety of rituximab maintenance therapy in follicular lymphomas
P Solal-Céligny
LEUKEMIA RESEARCH (2006)
Central tolerance: good but imperfect
AM Gallegos et al.
IMMUNOLOGICAL REVIEWS (2006)
SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond
GA Koretzky et al.
NATURE REVIEWS IMMUNOLOGY (2006)
T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens
R Ivanov et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity
LT van der Veken et al.
GENE THERAPY (2005)
Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells
SA Xue et al.
BLOOD (2005)
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR
CJ Cohen et al.
JOURNAL OF IMMUNOLOGY (2005)
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes
T Tsuji et al.
BLOOD (2005)
Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes
B Engels et al.
HUMAN GENE THERAPY (2005)
NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses
F van Rhee et al.
BLOOD (2005)
UTY-specific TCR-transfer generates potential graft-versus-leukaemia effector T cells
R Ivanov et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tunior cell lines
YB Zhao et al.
JOURNAL OF IMMUNOLOGY (2005)
In vitro and in vivo characterization of a novel antibody-like single-chain TCR human IgG1 fusion protein
LA Mosquera et al.
JOURNAL OF IMMUNOLOGY (2005)
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions
MS Hughes et al.
HUMAN GENE THERAPY (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Directed evolution of human T-cell receptors with picomolar affinities by phage display
Y Li et al.
NATURE BIOTECHNOLOGY (2005)
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-Cell receptor
JJ Roszkowski et al.
CANCER RESEARCH (2005)
Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer
KBJ Scholten et al.
CLINICAL IMMUNOLOGY (2005)
A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity
KF Card et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Reconstitution of anti-HIV effector functions of primary human CD8 T lymphocytes by transfer of HIV-specific αβ TCR genes
T Ueno et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cellular immune responses to the hepatitis B virus polymerase
E Mizukoshi et al.
JOURNAL OF IMMUNOLOGY (2004)
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
MHM Heemskerk et al.
BLOOD (2003)
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens
RA Morgan et al.
JOURNAL OF IMMUNOLOGY (2003)
Stable, soluble T-cell receptor molecules for crystallization and therapeutics
JM Boulter et al.
PROTEIN ENGINEERING (2003)
Reconstitution of CD8+ T cells by retroviral transfer of the TCR αβ-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte
H Tahara et al.
JOURNAL OF IMMUNOLOGY (2003)
Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCRαβ genes into primary human T lymphocytes
N Schaft et al.
JOURNAL OF IMMUNOLOGY (2003)
Initiation of TCR signaling:: regulation within CD3 dimers
B Alarcón et al.
IMMUNOLOGICAL REVIEWS (2003)
Direct observation of ligand recognition by T cells
DJ Irvine et al.
NATURE (2002)
TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning
CA Aarnoudse et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Generation of functional antiqen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells
L Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self
J Derbinski et al.
NATURE IMMUNOLOGY (2001)
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7
AA Jungbluth et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer
T Stanislawski et al.
NATURE IMMUNOLOGY (2001)
Immunotherapy through TCR gene transfer
HWHG Kessels et al.
NATURE IMMUNOLOGY (2001)
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex
MHM Heemskerk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigen
C Öhlén et al.
JOURNAL OF IMMUNOLOGY (2001)
Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide
RJ Orentas et al.
CLINICAL IMMUNOLOGY (2001)
High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL
MA Derby et al.
JOURNAL OF IMMUNOLOGY (2001)
Changing T cell specificity by retroviral T cell receptor display
HWHC Kessels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes
LJN Cooper et al.
JOURNAL OF VIROLOGY (2000)
Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR
RA Willemsen et al.
GENE THERAPY (2000)
In vitro evolution of a T cell receptor with high affinity for peptide/MHC
PD Holler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
